SIC
UPB

SJS Investment Consulting’s Upstream Bio Inc UPB Stock Holding History

SJS Investment Consulting’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$526 Buy
76
+74
+3,700% +$620 ﹤0.01% 2258
2026
Q1 		$18 Buy
+2
New +$36 ﹤0.01% 2382

Other funds holding UPB

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

SJS Investment Consulting's UPB Position: Q2 2026 in Review

SJS Investment Consulting increased its Upstream Bio Inc (UPB) stake by 3,700% in Q2 2026, buying an estimated $620 and bringing the position to 76 shares worth $526. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

SJS Investment Consulting first reported a position in UPB in Q1 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

  • SJS Investment Consulting held 76 shares of Upstream Bio Inc worth $526 as of Q2 2026.
  • SJS Investment Consulting bought 74 Upstream Bio Inc shares in Q2 2026, an estimated $620.
  • Upstream Bio Inc made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2258 holding.
  • SJS Investment Consulting first reported a position in Upstream Bio Inc in Q1 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.